Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

USA - NYSE:CLH - US1844961078 - Common Stock

243.59 USD
+7.15 (+3.02%)
Last: 10/23/2025, 8:04:00 PM
243.9 USD
+0.31 (+0.13%)
After Hours: 10/23/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLH. CLH was compared to 82 industry peers in the Commercial Services & Supplies industry. CLH scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, CLH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CLH had positive earnings in the past year.
CLH had a positive operating cash flow in the past year.
CLH had positive earnings in each of the past 5 years.
In the past 5 years CLH always reported a positive cash flow from operatings.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

CLH's Return On Assets of 5.17% is fine compared to the rest of the industry. CLH outperforms 70.73% of its industry peers.
With a decent Return On Equity value of 14.18%, CLH is doing good in the industry, outperforming 78.05% of the companies in the same industry.
CLH's Return On Invested Capital of 7.62% is fine compared to the rest of the industry. CLH outperforms 70.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLH is in line with the industry average of 10.38%.
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROIC 7.62%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of CLH (6.48%) is better than 74.39% of its industry peers.
In the last couple of years the Profit Margin of CLH has grown nicely.
Looking at the Operating Margin, with a value of 10.96%, CLH is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
In the last couple of years the Operating Margin of CLH has grown nicely.
The Gross Margin of CLH (30.76%) is comparable to the rest of the industry.
CLH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLH is still creating some value.
CLH has about the same amout of shares outstanding than it did 1 year ago.
CLH has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CLH is higher compared to a year ago.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.41 indicates that CLH is not in any danger for bankruptcy at the moment.
CLH's Altman-Z score of 3.41 is fine compared to the rest of the industry. CLH outperforms 68.29% of its industry peers.
CLH has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as CLH would need 7.39 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.39, CLH is doing good in the industry, outperforming 62.20% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that CLH has dependencies on debt financing.
With a Debt to Equity ratio value of 1.02, CLH is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Altman-Z 3.41
ROIC/WACC0.97
WACC7.86%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.45 indicates that CLH has no problem at all paying its short term obligations.
CLH has a better Current ratio (2.45) than 78.05% of its industry peers.
A Quick Ratio of 2.07 indicates that CLH has no problem at all paying its short term obligations.
The Quick ratio of CLH (2.07) is better than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.07
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for CLH have decreased by -1.79% in the last year.
Measured over the past years, CLH shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.46% on average per year.
CLH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
CLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.54% yearly.
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.25% on average over the next years. This is quite good.
CLH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y3.26%
EPS Next 2Y10.81%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue Next Year2.72%
Revenue Next 2Y4.08%
Revenue Next 3Y5.44%
Revenue Next 5Y4.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

CLH is valuated quite expensively with a Price/Earnings ratio of 34.21.
CLH's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.67, CLH is valued a bit more expensive.
CLH is valuated quite expensively with a Price/Forward Earnings ratio of 26.74.
The rest of the industry has a similar Price/Forward Earnings ratio as CLH.
CLH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.33.
Industry RankSector Rank
PE 34.21
Fwd PE 26.74
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLH is on the same level as its industry peers.
CLH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.71
EV/EBITDA 13.52
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CLH may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.5
PEG (5Y)1.09
EPS Next 2Y10.81%
EPS Next 3Y15.54%

0

5. Dividend

5.1 Amount

CLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (10/23/2025, 8:04:00 PM)

After market: 243.9 +0.31 (+0.13%)

243.59

+7.15 (+3.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners92.69%
Inst Owner Change-0.15%
Ins Owners5.55%
Ins Owner Change-3.87%
Market Cap13.06B
Revenue(TTM)5.94B
Net Income(TTM)384.77M
Analysts81.25
Price Target262.49 (7.76%)
Short Float %2.64%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.54%
Min EPS beat(2)-2.32%
Max EPS beat(2)1.24%
EPS beat(4)2
Avg EPS beat(4)1.98%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)9
Avg EPS beat(12)4.09%
EPS beat(16)13
Avg EPS beat(16)10.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)-1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)0.03%
Revenue beat(8)3
Avg Revenue beat(8)-1.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.41%
Revenue beat(16)10
Avg Revenue beat(16)1.55%
PT rev (1m)-0.15%
PT rev (3m)0.77%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)2.89%
EPS NY rev (1m)0.49%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 34.21
Fwd PE 26.74
P/S 2.2
P/FCF 34.71
P/OCF 17.35
P/B 4.81
P/tB 23.45
EV/EBITDA 13.52
EPS(TTM)7.12
EY2.92%
EPS(NY)9.11
Fwd EY3.74%
FCF(TTM)7.02
FCFY2.88%
OCF(TTM)14.04
OCFY5.76%
SpS110.8
BVpS50.61
TBVpS10.39
PEG (NY)10.5
PEG (5Y)1.09
Graham Number90.04
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROCE 10.13%
ROIC 7.62%
ROICexc 8.55%
ROICexgc 13.72%
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
FCFM 6.33%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexgc growth 3Y10.92%
ROICexgc growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Debt/EBITDA 2.55
Cap/Depr 86.82%
Cap/Sales 6.34%
Interest Coverage 4.19
Cash Conversion 69.4%
Profit Quality 97.81%
Current Ratio 2.45
Quick Ratio 2.07
Altman-Z 3.41
F-Score7
WACC7.86%
ROIC/WACC0.97
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
EPS Next Y3.26%
EPS Next 2Y10.81%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%
Revenue Next Year2.72%
Revenue Next 2Y4.08%
Revenue Next 3Y5.44%
Revenue Next 5Y4.88%
EBIT growth 1Y1.33%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year74.56%
EBIT Next 3Y28.7%
EBIT Next 5Y19.79%
FCF growth 1Y15.34%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y3.15%
OCF growth 3Y12.52%
OCF growth 5Y13.49%